Meeder Asset Management Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$14.8 - $21.15 $7,340 - $10,490	-496 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$15.21 - $25.53 $8,897 - $14,935	-585 Reduced 54.12%	496 $7,000
Q2 2020 Aug 11, 2020	BUY	$15.08 - $26.0 $14,823 - $25,558	983 Added 1003.06%	1,081 $28,000
Q1 2020 May 15, 2020	BUY	$11.0 - $19.76 $1,078 - $1,936	98 New	98 $1,000
Q4 2018 Jan 17, 2019	SELL	$16.25 - $28.09 $731 - $1,264	-45 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$13.23 - $30.93 $595 - $1,391	45 New	45 $0

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $676M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.